Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

SUMO2/3 CHIP-Seq in HL-60 cells treated or not with cytarabine or daunorubicine

ABSTRACT: SUMO2/3 CHIP-Seq in HL-60 cells treated or not with cytarabine or daunorubicine

PROVIDER: PRJNA817623 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Similar Datasets

SUMO2/3 CHIP-Seq in HL-60 cells treated or not with cytarabine or daunorubicine

Project description:SUMOylation, a post-translational modification of the ubiquitin family plays key roles in Acute Myeloid Leukemias response to therapies, in particular through the regulation of gene expression. We have investigated here how daunorubicine (DNR) and cytarabine (Ara-C), the two main drugs used for Acute Myeloid Leukemia treatment, affect the distribution of SUMO on chromatin in the HL-60 cell lines. We found that DNR but not Ara-C leads to a massive decrease in the presence of SUMOylated proteins on the chromatin, in particular at promoters and enhancers, where they are enriched.

2023-06-23 | GSE198985 | GEO

RNA-Seq analysis of HL-60 AML cells resistant to daunorubicin or cytarabine

Project description:The Acute Myeloid Leukemia cell line HL-60 was rendered resistant to daunorubicin (DNR) or cytarabine (Ara-C) by continuous exposure to the drug up to concentrations of 30nM for DNR and 100nM for Ara-C. Transcriptomic analysis were then performed by RNA-Seq to compare the cell lines

2022-01-08 | GSE193094 | GEO

HL-60 treated with TPA

Project description:Comparing the difference between TPA stimulated HL-60 and control

2013-05-05 | GSE29620 | GEO

RNA-Seq analysis of HL-60 AML cells resistant to daunorubicin or cytarabine

Project description:RNA-Seq analysis of HL-60 AML cells resistant to daunorubicin or cytarabine

| PRJNA794751 | ENA

Epichromatin HL-60/S4

Project description:Epichromatin HL-60/S4

| PRJEB5782 | ENA

Control ChIP-seq from HL-60 (ENCSR309MYO)

Project description:ChIP-seq on human HL-60 For data usage terms and conditions, please refer to http://www.genome.gov/27528022 and http://www.genome.gov/Pages/Research/ENCODE/ENCODE_Data_Use_Policy_for_External_Users_03-07-14.pdf

2021-02-27 | GSE167618 | GEO

Histone ChIP-seq from HL-60 (ENCSR198IHT)

Project description:H3K27me3 ChIP-seq on human HL-60 For data usage terms and conditions, please refer to http://www.genome.gov/27528022 and http://www.genome.gov/Pages/Research/ENCODE/ENCODE_Data_Use_Policy_for_External_Users_03-07-14.pdf

2021-05-23 | GSE175082 | GEO

Histone ChIP-seq from HL-60 (ENCSR919WLM)

Project description:H3K27ac ChIP-seq on human HL-60 For data usage terms and conditions, please refer to http://www.genome.gov/27528022 and http://www.genome.gov/Pages/Research/ENCODE/ENCODE_Data_Use_Policy_for_External_Users_03-07-14.pdf

2021-02-27 | GSE167788 | GEO

Gene expression profiling in Dip G-treated HL-60 cells

Project description:To understand the function of the small molecule Dip G, the gene expression profiles of HL-60 cells treated with Dip G were analyzed using the microarray.

2017-07-31 | GSE84652 | GEO

RNA-seq of decitabine- and RG3039-treated WT HL-60 cells

Project description:We performed stranded RNA-seq on HL-60 cells treated with decitabine for 6 hours, 72 hours and 120 hours in duplicate.

2023-01-13 | GSE222823 | GEO